Jeff Stier, director of the National Center for Public Policy Research’s Risk Analysis Division, asks Pfizer CEO Ian Read about his company’s position on “academic detailing.”  Academic detailing empowers academics selected by the government to guide how medical care and prescription drugs are delivered to … Continue reading Jeff Stier, Pfizer CEO Criticize “Academic Detailing” in Health Care